The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause
Abstract
Following the arrest of estradiol secretion by the ovaries at menopause, all estrogens and all androgens in postmenopausal women are made locally in peripheral target tissues according to the physiological mechanisms of intracrinology. The locally made sex steroids exert their action and are inactivated intracellularly without biologically significant release of the active sex steroids in the circulation. The level of expression of the steroid-forming and steroid-inactivating enzymes is specific to each cell type in each tissue, thus permitting to each cell/tissue to synthesize a small amount of androgens and/or estrogens in order to meet the local physiological needs without affecting the other tissues of the organism. Achieved after 500 million years of evolution, combination of the arrest of ovarian estrogen secretion, the availability of high circulating levels of DHEA and the expression of the peripheral sex steroid-forming enzymes have permitted the appearance of menopause with a continuing access to intratissular sex steroids for the individual cells/tissues without systemic exposure to circulating estradiol. In fact, one essential condition of menopause is to maintain serum estradiol at biologically inactive (substhreshold) concentrations, thus avoiding stimulation of the endometrium and risk of endometrial cancer. Measurement of the low levels of serum estrogens and androgens in postmenopausal women absolutely requires the use of MS/MS-based technology in order to obtain reliable accurate, specific and precise assays. While the activity of the series of steroidogenic enzymes can vary, the serum levels of DHEA show large individual variations going from barely detectable to practically normal "premenopausal" values, thus explaining the absence of menopausal symptoms in about 25% of women. It should be added that the intracrine system has no feedback elements to adjust the serum levels of DHEA, thus meaning that women with low DHEA activity will not be improved without external supplementation. Exogenous DHEA, however, follows the same intracrine rules as described for endogenous DHEA, thus maintaining serum estrogen levels at substhreshold or biologically inactive concentrations. Such blood concentrations are not different from those observed in normal postmenopausal women having high serum DHEA concentrations. Androgens, on the other hand, are practically all made intracellularly from DHEA by the mechanisms of intracrinology and are always maintained at very low levels in the blood in both pre- and postmenopausal women. Proof of the importance of intracrinology is also provided, among others, by the well-recognized benefits of aromatase inhibitors and antiestrogens used successfully for the treatment of breast cancer in postmenopausal women where all estrogens are made locally. Each medical indication for the use of DHEA, however, requires clinical trials performed according to the FDA guidelines and the best rules of clinical medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, peripheral tissues produce estrogens71, and estrogens play a vital role in wound healing27,28.”
From Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells (2020) · cites this paper as [71]
In the citing paper
“It should be noted that this peripheral estrogen production often functions in a paracrine and intracrine manner and as such circulating concentrations are not reflective of the concentrations achieved locally [304,305].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [305]
Citations
Cites
Association of Exogenous Estrogen and Endometrial Carcinoma
SMITH, D. C. C., Prentice, R. L., Thompson, D. J., & HERRMANN, W. L. (1975) · New England Journal of Medicine · doi:10.1056/nejm197512042932302 · Cited by 960
Important Advances in Oncology: 1986
Merrill, J. M. (1986) · JAMA · doi:10.1001/jama.1986.03380040106043 · Cited by 909
Gold, E. B. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.5.463 · Cited by 861
Labrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685
Self-citationEffects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women
Judd, H. L. (1996) · JAMA · doi:10.1001/jama.1996.03530290040035 · Cited by 605
Bulun, S. E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Gurates, B., et al. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.6 · Cited by 531
The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
Labrie, F., Luu-The, V., Lin, S.-X., Claude, L., Simard, J., Breton, R., & Bélanger, A. (1997) · Steroids · doi:10.1016/s0039-128x(96)00174-2 · Cited by 480
Self-citationIs dehydroepiandrosterone a hormone?
Labrie, F., Luu-The, V., Bèlanger, A., Lin, S.-X., Simard, J., Pelletier, G., & Labrie, C. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06264 · Cited by 460
Self-citationBurger, H. G., Dudley, E. C., Cui, J., Dennerstein, L., & Hopper, J. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6740 · Cited by 439
WHO Technical Report Series No. 72
&NA; (1954) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195408000-00072 · Cited by 432
Flagged first, then by citations
1 of the 50 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Labrie, 2010, DHEA after menopause–sole source of sex steroids and potential sex steroid deficiency treatment, Menopause Management, 19, 14
- Labrie, 2006, Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women, J. Steroid Biochem. Mol. Biol., 99, 182, 10.1016/j.jsbmb.2006.02.004 · DOI
Cited by
Sorted by citations
Items 201–227 of 227
Adipose Tissue Produced Estrogen as Risk Factors for Cancers
Husain, H., Ahmad, R., & Waseem, M. (2021) · Springer eBooks · doi:10.1007/978-981-16-1846-8_2
Circulating Expressions of Gonadotropin Releasing Hormones and Risk of Ovarian Cancer
Parveen, G., Hassan, A. H., Rehm, M. H., Altaf, A., Zahra, N., Malik, A., Naz, A., & Sattar, H. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2115113372
Sex Steroid Actions in the Male
Vanderschueren, D., Antonio, L., Kim, N. R., & Claessens, F. (2022) · doi:10.1093/med/9780198870197.003.0481
Löfqvist, H. (2021) · Springer eBooks · doi:10.1007/978-3-662-62710-5_2
DHEA bei Depression nach Brustkrebs?
Heidelberg, S.-V. B. (2016) · best practice onkologie · doi:10.1007/s11654-016-5272-9
Association of Estrogen and Progesterone with Ovarian Cancers
Mudassir, A. Q., Zafar, A., Zia, U., Saboor, R., Rasheed, T., & Soomro, S. B. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22168301
Postmenopausal sexual function and steroid hormone levels: a hospital-based cross-sectional study
Nunes, E., Gallardo, E., Nunes, S., & Fonseca-Moutinho, J. A. (2023) · Climacteric · doi:10.1080/13697137.2023.2171286
“menopause have already decreased 60% [13].”
(2023) · doi:10.31038/awhc.2023611
“Unfortunately, only a little circulating oestradiol survives in the postmenopausal woman—less than 30 pg/mL indirectly originating from adrenal androgens after conversion via estrone in adipose tissue [2,3].”
BackgroundSim, J., & Kwon, K. H. (2023) · Asian Journal of Beauty and Cosmetology · doi:10.20402/ajbc.2023.0029
Peni, L. W., Falah, P. M., & Nurdian, Y. (2024) · Journal Of Vocational Health Studies · doi:10.20473/jvhs.v8.i1.2024.13-19
“Women exhibit varying serum levels of endogenous DHEA, with 25% of them having high DHEA levels to avoid the menopausal syndrome (Labrie, 2015b; Labrie, 2015c).”
BackgroundSignificance of Adipose Tissue as an Endocrine Organ
Avtanski, D. B., & Stojchevski, R. (2024) · Contemporary Endocrinology · doi:10.1007/978-3-031-72570-8_1
Menopause: The Concepts and the Biological Background
Cano, A., Monllor-Tormos, A., Carrasco-Catena, A., & Belda-Montesinos, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-83979-5_2 · Cited by 1
Nagasato, Y., Sanematsu, K., Kawabata, Y., Takai, S., & Shigemura, N. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113295
Miyamoto, Y., Hirai, W., Saka, T., Tanio, M., Kudo, Y., Yoshino, Y., Nakagawa, Y., Kobayashi, N., Takada, S., Okada, T., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118649
Glaser, R. L. (2026) · Cureus · doi:10.7759/cureus.106377
“The biologically active hormones T, E2 (derived from T via aromatase), and DHT (from T via 5 α -reductase) exert tissue-specific effects through nuclear receptors (AR for T/DHT; ER α / β for E2) and non-genomic pathways [14].”
InfluentialRetractedNovel SOAT inhibitors block DHEAS transport and suppress proliferation in MCF-7 breast cancer cells
Karakus, E., Leiting, S., Daude, M., Diederich, W. E., & Geyer, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-47803-0
Long, C., Huang, C., Chang, C., Loo, Z.-X., Feng, C., Sung, I.-C., & Lin, K. (2026) · Gynecologic and Obstetric Investigation · doi:10.1159/000552775
Ottey, S., Pokuah, F., Cree, M. G., Sherif, K., Vesper, H. W., Lyle, A. N., & Azziz, R. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag276
Wang, R., Wang, X., Su, P., Roy, J., Poirier, D., & Lin, S. (2026) · Cells · doi:10.3390/cells15151345
“After menopause, the ovaries stop secreting estradiol, making DHEA, a precursor steroid of adrenal origin, the sole source of all estrogens and androgens in postmenopausal women [31].”
Estrogen Receptors and Enzymes Involved in Estrogen Synthesis as Breast Cancer Treatment Targets
Licznerska, B. E., Szaefer, H., Sobierajska, H., & Baer‐Dubowska, W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156823
“Therefore, in postmenopausal women, sex steroids, including estrogens, are predominantly produced in extragonadal tissues from adrenal precursors, a system termed “intracrinology” [4].”
Cardiovascular Effects of Sex Hormones and Their Receptors
Molezini, L., Xia, W., & Khalil, R. A. (2026) · Physiology in health and disease · doi:10.1007/978-3-032-26472-5_6
Agarwal, S., Maran, S., Patra, S., Gurumurthy, S., Bharathselvi, M., Chitradevi, R., Bhambhani, V. G., Mugundhan, D. R., Leonardi, A., & Angayarkanni, N. (2026) · The Ocular Surface · doi:10.1016/j.jtos.2026.08.003
Salinas, C., Vallejo, M. S. C., Blümel, J. E., Chedraui, P., Aedo, S., Elizalde-Cremonte, A., Monterrosa-Castro, Á., Calle, A., Gómez, C. E., Rey, C., et al. (2026) · Climacteric · doi:10.1080/13697137.2026.2735782
Gu, H., LIU, J., Zhao, Y., 姜彩肖, & Liu, Z. (2026) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.71427
Metadata
- Authors
- Labrie, F.
- Corresponding author
- Labrie, Fernand
- Venue
- The Journal of Steroid Biochemistry and Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 145
- Pages
- 133-138
- ISSN
- 0960-0760 (ISSN-L)
- OpenAlex
- W1969438694
- Cited by
- 227
- References
- 50
- Citations by year
- 2026: 15 · 2025: 8 · 2024: 14 · 2023: 14 · 2022: 17 · 2021: 18 · 2020: 14 · 2019: 17 · 2018: 24 · 2017: 34 · 2016: 29 · 2015: 19
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Steroid Biochemistry and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- intracrinology, menopause, postmenopausal women, androgen production, dehydroepiandrosterone, steroidogenic enzymes, serum estradiol, endometrial cancer risk, DHEA supplementation, menopausal symptoms, androgen insensitivity syndrome
- MeSH terms
- Breast Neoplasms, Dehydroepiandrosterone, Estrogens, Female, Humans, Hydrocortisone, Menopause, Ovary, Progesterone, Steroids, Estrogen Receptor Modulators, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review